HIKMA Pharmaceuticals PLC Logo

HIKMA Pharmaceuticals PLC

ISIN: GB00B0LCW083 | Ticker: HIK | LEI: 213800HEZ5RG2KU77V41
Sector: Health CareSub-Industry: Pharmaceuticals
Country: United Kingdom

About HIKMA Pharmaceuticals PLC

Company Description

Hikma Pharmaceuticals PLC is a global pharmaceutical company that is dedicated to providing high-quality, affordable medications to patients worldwide. With its headquarters in London, UK, and operations in the Middle East, Africa, Europe, and the United States, Hikma has established itself as a leader in the pharmaceutical industry.

The company has a diversified product portfolio that includes branded, generic, and injectable pharmaceuticals. Its focus is on developing and manufacturing innovative solutions for complex diseases, such as oncology, respiratory, and injectables.

Year founded

1978

Served area

Worldwide

Headcount

8,700

Headquarters

1 New Burlington Place, W1S 2HR London – United Kingdom

Filings & Publications

Sign up and we will give you access!

Insider Trades

Sign up and we will give you access!

Short Interest


Current short interest

Position Holder Short Interest in Percent Date
Millennium International Management LP 0.69% 17.10.23
Millennium International Management LP 0.60% 03.11.23
Millennium International Management LP 0.59% 25.10.23
Millennium International Management LP 0.52% 11.09.23
Millennium International Management LP 0.53% 29.09.23
Millennium International Management LP 0.63% 28.02.24
Millennium International Management LP 0.73% 10.10.23
Millennium International Management LP 0.70% 24.01.24
Millennium International Management LP 0.64% 06.03.24
Millennium International Management LP 0.59% 13.11.23
Millennium International Management LP 0.57% 31.01.24
Millennium International Management LP 0.51% 08.01.24
Total 7.30%

Capital markets information

ISIN

GB00B0LCW083

LEI

213800HEZ5RG2KU77V41

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

Sub-Industry

Pharmaceuticals

Listed Stock Exchange

London Stock Exchange

Stock Index

FTSE 250

Main Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.